KD 7040
Alternative Names: KD-7040Latest Information Update: 18 Aug 2011
At a glance
- Originator Kalypsys
- Class Analgesics
- Mechanism of Action Nitric oxide synthase type II inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Neuropathic pain
Most Recent Events
- 19 Dec 2007 Phase-II clinical trials in Neuropathic pain in USA (Topical)
- 17 Apr 2007 Phase-I clinical trials in Neuropathic pain in USA (Topical)